About this Webinar:
This webinar will describe what is known about cognitive rigidity, or how patients with eating disorders get stuck in thinking patterns that cause suffering and can give rise to unhealthy patterns of eating and exercise. We will then discuss how new treatments such as psilocybin and ketamine might help patients shift out of these rigid thought and behavior patterns. We will share information about what is known about these treatments and what trials are ongoing.
Presenter Bio:
Marissa Raymond-Flesch, MD, MPH
Dr. Raymond-Flesch is a Professor in the University of California San Francisco (UCSF) Division of Adolescent and Young Adult Medicine and its interdisciplinary Eating Disorder Program. Clinically, she practices Adolescent and Young Adult Medicine with patients 12 to 26 years old, including primary care and the treatment of eating disorders, depression, and anxiety. Her research includes investigating novel therapeutics for the treatment of eating disorders and equitable access to medical care for marginalized populations. She is the Principal Investigator for the Study of Psilocybin for Anorexia Nervosa in Young Adults (SPANYA), an ongoing clinical trial.
Amanda Downey, MD
Amanda Downey is a pediatrician and child and adolescent psychiatrist who cares for adolescents and young adults with eating disorders. She works with patients and their families to develop a treatment plan that honors their unique strengths and challenges. Through education, advocacy and research, she strives to dismantle the systems that increase risk for eating disorders and improve evidence-based eating disorder treatments. She is the assistant medical director of the UCSF Eating Disorders Program, Principal Investigator in the Ketamine Effects on Learning In Eating Disorders trial and a co-investigator in the Study of Psilocybin for Anorexia Nervosa in Young Adults
.
Date: Wednesday, February 4, 2026
Time: 9:00 AM Pacific / 12:00 PM Eastern / 5:00 PM UK
Location: Zoom Platform
United States
Register below